US giants are rushing to partner with Indian and Chinese companiestapping their brainpower and saving millions of dollars in the search for breakthrough treatments
Former United States President Barack Obama has been free from the pressures of running the nation for two years now. However, while in office and even out of it, Obama has always enjoyed each moment. As he celebrates his 57th birthday (August 4), here are some of his lighter moments enjoying life.
The Bharathidasan University and Mediscan Institute of Medical Education, Chennai invite applications for admission to their job-oriented full-time, two year, diploma programmes.
Patni Computer Systems Inc, a wholly-owned subsidiary of Patni Computer Systems, on Monday announced the acquisition of Bridgewater, NJ-based Taratec Development Corp for an aggregate price of $27.2 million in cash.
VIGSR, in Mumbai, offers the first postgraduate diploma in medical genetics in India.
India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.
Canada has offered its partnership in areas like agriculture, mining, life sciences, ICT, financial services and infrastructure. Canada's aim in India was to create new Canadian connections in sectors like agriculture, mining, life sciences, information and communication technology (ICT), financial services and infrastructure, areas where that country's firms have proven expertise. Canadian rep hoped to see Canadian companies becoming active in the Indian market & vice versa.
The west is faced with a daunting task on patent expiry, increasing challenges from generics, pipeline showing limited blockbusters, and in addition to that increasing pricing pressure.
'There is no one who will be able to have a dignified life, when your brother and sister of another community are not being treated as human.'
Many films and shows go back in time to bring alive so many fading and forgotten memories.
Ranbaxy board has approved the hive off of its R&D unit, with an 1:4 share swap ratio.
Readers have responded resoundingly to our invitation to congratulate the ISRO team for Chandrayaan-3's successful Moon landing.
In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.
Union Health Secretary Rajesh Bhushan reviewed the status of passengers coming from the UK to India and found positive in Maharashtra, Karnataka, Telangana, Tamil Nadu, West Bengal, Goa, Punjab, Gujarat and Kerala and their response measures in a meeting held through video conferencing.
The Institute of Clinical Research (India) invites applications for its one-year part-time Professional Certificate Programme in Clinical Research and Trials Management and the Professional Certificate Programme in Regulatory Affairs and Ethics.
Scientists associated with Indian SARS-CoV-2 Consortium on Genomics (INSACOG), the government panel that conducts research on different variants of the coronavirus, said they were surprised at noted virologist Shahid Jameel's decision to quit the group and wondered whether he was disillusioned with the government's handling of the pandemic.
In a landmark overhaul of colonial-era criminal laws, the Centre on Friday introduced in the Lok Sabha three bills to replace the IPC, CrPC and the Indian Evidence Act, proposing among other things repeal of the sedition law and introducing a new provision with a wider definition of the offence.
The improving outlook for the power sector has caught the interest of dividend yield funds. In the first four months of the current financial year (2023-24, or FY24), five of the six largest dividend yield funds have shown a notable increase in their exposure to stocks within the power sector. Some have even introduced new stocks to their portfolios.
The Welingkar Institute of Management, India, and Nottingham Trent University, UK, invite applications for their M Sc Bioinformatics programme.
Biovel Life Sciences (P) Ltd, a biotechnology firm, has inked a licensing agreement with US-based Dowpharma to produce Human Growth Hormone using Pfenex Expression Technology, for the first time globally.
Reliance Pharmaceuticals, the proposed pharmaceutical manufacturing company promoted by Mukesh Ambani's Reliance Life Sciences, will soon rope in a consultant to give final shape to the project, slated to take off within two years.
Competing with established biotech companies in India such as Wockhardt, Biocon and Reliance Life Sciences, small biotech companies such as Zenotech, BV Biocorp and Intas Biopharma are likely to emerge as major players in biogeneric drugs.
Fundraising activity in the upcoming financial year 2022-23 may even surpass FY22 when 52 Indian companies raised a record Rs 1.11 trillion via initial public offerings (IPOs). According to a note by PRIME Database, 54 companies (including LIC) plan to raise Rs 1.4 trillion and currently hold the Securities and Exchange Board of India's (Sebi's) approval. Another 43 companies, the note said, are looking to raise about Rs 81,000 crore but waiting for Sebi nod.
Global pharma and biotech companies, especially those from US, Europe and Japan, are keen to sign agreements with Indian companies, according to experts.
Prime Minister Narendra Modi on Tuesday met prominent US personalities from different walks of life, including Tesla CEO Elon Musk who asserted that India has more promise than any other large country and that he is incredibly excited about its future.
Signs of alien life will be detected by 2025, while "definitive evidence" of extra-terrestrial beings may be found within the next 20 to 30 years, top NASA scientists say.
Sukanya Verma covers the whole spectrum for you.
Despite news of the private equity in the domestic healthcare and pharma industry touching almost Rs 40 crore (Rs 40 million) in the first nine months of the year, PE firms are not exactly bullish about investing in the pharma industry alone. In fact, a closer look at the investments reveals that a larger part of the money is being flown into healthcare delivery systems like hospital chains and not in pharma companies.
Will Vijay will go the most successful MGR/Jayalalithaa way, or that of Vijayakanth, Seeman or Kamalahaasan, or will he end up as another Rajinikanth who cries wolf at the last minute and quits the scene even before it all had really begun, asks N Sathiya Moorthy.
Springing a surprise, the Bharatiya Janata Party on Monday picked Mohan Yadav, a leader of Other Backward Classes (OBC) and a three-time MLA, as the next chief minister of Madhya Pradesh, state party president VD Sharma said.
A GLOF occurred in parts of Lhonak Lake, leading to a rapid rise in water levels with very high velocities downstream along the Teesta River Basin in the early hours of October 4. This resulted in severe damage in Mangan, Gangtok, Pakyong and Namchi districts.
'It's vital that over the next 10 years, that India, the US and the Artemis Accords family of nations come together to ensure that we not only return humanity to the moon, but that we build the technology that will allow us stay there permanently.' 'And then go on to Mars.'
Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research for central nervous system disorder.
Software services firm Netkraft on Thursday said it is being acquired by the privately held business process and technology consulting company, the United States-based Adea Solutions, in an all-cash deal.
In a nation of 1.4 billion people, where a potential new creator is born every second, we pick 25 influencers who have ruled social media this year.
Post all your college and career-related questions right here on rediffGURUS and let our experts answer.
'Looking back, there is every chance that I would not have opted for Kota.'' 'The biggest flaw is that your personality gets blocked.' 'It took me two years to get back to 'being human' again.'
Hyderabad is fast emerging as destination for pharma and bio-tech industries with projected growth of 30 to 40 per cent, consultant company Frost and Sullivan has said.
